Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Safer

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Attention Disorders|October 22, 2015
Recent Trends in Stimulant UsageDaniel J Safer
The Journal of Nervous and Mental Disease|June 25, 2021
A Critique on Psychiatric Inpatient Admissions for Suicidality in YouthDaniel J Safer
Bipolar Disorders|November 3, 2010
Mood swing and mood stabilizer: how specific are these terms?Daniel J Safer
Journal of Clinical Psychopharmacology|July 3, 2004
A comparison of risperidone-induced weight gain across the age spanDaniel J Safer
The Journal of Nervous and Mental Disease|July 31, 2013
Number needed to harm: its limitations in psychotropic drug safety researchDaniel J Safer, Julie M Zito
Frontiers in Psychiatry|November 5, 2019
Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and ConcernsDaniel J Safer, Julie Magno Zito
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescentsDaniel J Safer, Julie Magno Zito
Pharmacoepidemiology and Drug Safety|November 28, 2007
Is there a connection between methylphenidate and cancer in youth?Julie Magno Zito, Daniel J Safer
The Journal of Nervous and Mental Disease|November 2, 2013
Number needed to harmDaniel J Safer, Julie M Zito
The American Journal of Psychiatry|March 4, 2003
Concomitant psychotropic medication for youthsDaniel J Safer, Julie Magno Zito, Susan DosReis
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Attention Disorders|October 22, 2015
Recent Trends in Stimulant UsageDaniel J Safer
The Journal of Nervous and Mental Disease|June 25, 2021
A Critique on Psychiatric Inpatient Admissions for Suicidality in YouthDaniel J Safer
Bipolar Disorders|November 3, 2010
Mood swing and mood stabilizer: how specific are these terms?Daniel J Safer
Journal of Clinical Psychopharmacology|July 3, 2004
A comparison of risperidone-induced weight gain across the age spanDaniel J Safer
The Journal of Nervous and Mental Disease|July 31, 2013
Number needed to harm: its limitations in psychotropic drug safety researchDaniel J Safer, Julie M Zito
Frontiers in Psychiatry|November 5, 2019
Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and ConcernsDaniel J Safer, Julie Magno Zito
Journal of Child and Adolescent Psychopharmacology|March 24, 2006
Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescentsDaniel J Safer, Julie Magno Zito
Pharmacoepidemiology and Drug Safety|November 28, 2007
Is there a connection between methylphenidate and cancer in youth?Julie Magno Zito, Daniel J Safer
The Journal of Nervous and Mental Disease|November 2, 2013
Number needed to harmDaniel J Safer, Julie M Zito
The American Journal of Psychiatry|March 4, 2003
Concomitant psychotropic medication for youthsDaniel J Safer, Julie Magno Zito, Susan DosReis
Pageof 6